×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TSHA – taysha gene therapies, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TSHA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/2
09:44 am
tsha
Taysha Gene Therapies, Inc. (TSHA) Gains Wells Fargo's Support on Rett Syndrome Program Progress [Yahoo! Finance]
Low
Report
Taysha Gene Therapies, Inc. (TSHA) Gains Wells Fargo's Support on Rett Syndrome Program Progress [Yahoo! Finance]
1/29
04:42 pm
tsha
Here's What Analysts Are Saying About Taysha Gene Therapies (TSHA) [Yahoo! Finance]
Low
Report
Here's What Analysts Are Saying About Taysha Gene Therapies (TSHA) [Yahoo! Finance]
1/14
02:21 pm
tsha
Taysha Gene Therapies Inc. (TSHA): A Promising Biotech on Rett Syndrome Drug Prospects [Yahoo! Finance]
Low
Report
Taysha Gene Therapies Inc. (TSHA): A Promising Biotech on Rett Syndrome Drug Prospects [Yahoo! Finance]
1/6
03:01 pm
tsha
Taysha Gene Therapies (NASDAQ:TSHA) had its "strong-buy" rating reaffirmed by analysts at Raymond James Financial, Inc..
Low
Report
Taysha Gene Therapies (NASDAQ:TSHA) had its "strong-buy" rating reaffirmed by analysts at Raymond James Financial, Inc..
1/6
02:33 pm
tsha
Taysha Gene Therapies (NASDAQ:TSHA) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $12.00 price target on the stock.
Low
Report
Taysha Gene Therapies (NASDAQ:TSHA) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $12.00 price target on the stock.
1/6
08:00 am
tsha
Taysha Gene Therapies Announces Progress Across TSHA-102 Pivotal Gene Therapy Program in Rett Syndrome
Medium
Report
Taysha Gene Therapies Announces Progress Across TSHA-102 Pivotal Gene Therapy Program in Rett Syndrome
1/5
08:42 am
tsha
Taysha Gene Therapies (NASDAQ:TSHA) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
Medium
Report
Taysha Gene Therapies (NASDAQ:TSHA) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
Date
Time
Symbol
Company Name
Action
%Chg
11/4/2025
07:00 am
tsha
taysha gene therapies, inc.
IN-LINE
Report
-1.8%
taysha gene therapies, inc.
8/12/2025
08:01 am
tsha
taysha gene therapies, inc.
MISS
Report
-3.2%
taysha gene therapies, inc.
5/15/2025
08:00 am
tsha
taysha gene therapies, inc.
IN-LINE
Report
5.8%
taysha gene therapies, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/5
01:40 pm
tsha
Form SCHEDULE 13G/A Taysha Gene Therapies, Filed by: FMR LLC
Low
Report
Form SCHEDULE 13G/A Taysha Gene Therapies, Filed by: FMR LLC
2/4
06:44 pm
tsha
Form 144 Taysha Gene Therapies, Filed by: McGinnis Emily
Low
Report
Form 144 Taysha Gene Therapies, Filed by: McGinnis Emily
2/4
06:43 pm
tsha
Form 144 Taysha Gene Therapies, Filed by: Porter Fred
Low
Report
Form 144 Taysha Gene Therapies, Filed by: Porter Fred
2/4
06:41 pm
tsha
Form 144 Taysha Gene Therapies, Filed by: McAuliffe Sean
Low
Report
Form 144 Taysha Gene Therapies, Filed by: McAuliffe Sean
2/4
06:40 pm
tsha
Form 144 Taysha Gene Therapies, Filed by: Haque-Ahmed Rumana
Low
Report
Form 144 Taysha Gene Therapies, Filed by: Haque-Ahmed Rumana
2/4
06:39 pm
tsha
Form 144 Taysha Gene Therapies, Filed by: Alam Kamran
Low
Report
Form 144 Taysha Gene Therapies, Filed by: Alam Kamran
1/27
04:06 pm
tsha
Form 4 Taysha Gene Therapies, For: Jan 23 Filed by: Nagendran Sukumar
Medium
Report
Form 4 Taysha Gene Therapies, For: Jan 23 Filed by: Nagendran Sukumar
1/27
04:05 pm
tsha
Form 4 Taysha Gene Therapies, For: Jan 23 Filed by: Nolan Sean P.
Medium
Report
Form 4 Taysha Gene Therapies, For: Jan 23 Filed by: Nolan Sean P.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: